Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Becker

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Hematology/Oncology|June 25, 2020
Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue SarcomasOliver Uckunkaya, Peter Nöllke, Erika Hallmen, et al.
BMC Medicine|February 7, 2025
High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
European Journal of Neurology|March 26, 2026
Fluoroquinolone-Associated Peripheral and Central Nervous System-Related Disorders: A Large German Claims-Based Cohort StudyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Pharmacotherapy|April 26, 2025
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population-based propensity score-matched German cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
BMC Ophthalmology|August 7, 2025
Association between fluoroquinolones and retinal detachment: insights from a large German health claims-based cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Critical Reviews in Oncology/Hematology|October 11, 2005
Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemiasDietger Niederwieser, Chiara Gentilini, Ute Hegenbart, et al.
Cancer Reports (Hoboken, N.J.)|March 28, 2023
Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factorsMeike Ressing, Cornelia Becker, Christian Müller, et al.
Clinical and Translational Science|December 20, 2025
Key Stakeholders' Knowledge, Opinions, and Interests on Real-World Evidence in the Regulatory Process-Results of an EU-Wide SurveyFrank Lucas Depner, Martin Russek, Christoph Röthlein, et al.
Leukemia & Lymphoma|August 23, 2013
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemiaKarin Hebenstreit, Simona Iacobelli, Sabine Leiblein, et al.
The Journal of Infection|May 9, 2006
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosisDavid W Denning, Kieren A Marr, Wendi M Lau, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|June 25, 2020
Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue SarcomasOliver Uckunkaya, Peter Nöllke, Erika Hallmen, et al.
BMC Medicine|February 7, 2025
High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
European Journal of Neurology|March 26, 2026
Fluoroquinolone-Associated Peripheral and Central Nervous System-Related Disorders: A Large German Claims-Based Cohort StudyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Pharmacotherapy|April 26, 2025
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population-based propensity score-matched German cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
BMC Ophthalmology|August 7, 2025
Association between fluoroquinolones and retinal detachment: insights from a large German health claims-based cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Critical Reviews in Oncology/Hematology|October 11, 2005
Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemiasDietger Niederwieser, Chiara Gentilini, Ute Hegenbart, et al.
Cancer Reports (Hoboken, N.J.)|March 28, 2023
Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factorsMeike Ressing, Cornelia Becker, Christian Müller, et al.
Clinical and Translational Science|December 20, 2025
Key Stakeholders' Knowledge, Opinions, and Interests on Real-World Evidence in the Regulatory Process-Results of an EU-Wide SurveyFrank Lucas Depner, Martin Russek, Christoph Röthlein, et al.
Leukemia & Lymphoma|August 23, 2013
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemiaKarin Hebenstreit, Simona Iacobelli, Sabine Leiblein, et al.
The Journal of Infection|May 9, 2006
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosisDavid W Denning, Kieren A Marr, Wendi M Lau, et al.
Pageof 3